Panacea Biotec profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| −0.6% | −0.6% | −1.0% | −0.1% | −4.0% | ||
| −0.6% | −0.6% | −0.7% | −0.1% | −2.2% | ||
| −4.1% | −4.1% | −6.6% | −6.1% | −14.3% | ||
| −3.3% | −4.7% | −7.9% | −2.9% | −6.8% | ||
Margins | ||||||
| 0.3% | −0.7% | −4.6% | −3.6% | −21.3% | ||
| −5.9% | −5.9% | −10.9% | −10.2% | −29.8% | ||
| — | 28.5% | 4,937.5% | 80.9% | — | ||
| −1.5% | −1.2% | −1.4% | 0.3% | 2.8% | ||
| −1.3% | −1.1% | −1.6% | −0.3% | −7.3% | ||
| −1.1% | −0.8% | −1.5% | −0.2% | −7.3% | ||
| −5.9% | −5.9% | −13.9% | −13.9% | −101.0% | ||
Additional | ||||||
| 13.9% | 2.9% | −9.7% | 201.4% | 363.7% | ||
| −0.6% | −0.6% | −1.0% | −0.1% | −4.0% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.